Prophylactic thyroidectomy in medullary thyroid cancer

被引:0
作者
Peix, Jean-Louis [1 ]
Lifante, Jean Christophe [1 ]
Chazot, Francoise Borson [1 ]
Giraud, Sophie [1 ]
机构
[1] Ctr Hosp Lyon Sud, F-69495 Pierre Benite, France
来源
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE | 2012年 / 196卷 / 07期
关键词
CARCINOMA MEDULLARY; THYROID NEOPLASMS/SURGERY; GENETIC DISEASES INBORN; ENDOCRINE NEOPLASIA TYPE-2; RET PROTOONCOGENE; MALIGNANT PROGRESSION; GENE CARRIERS; CARCINOMA; MUTATION; GUIDELINES; PHENOTYPE; MEN; SURGERY;
D O I
10.1016/S0001-4079(19)31708-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Medullary thyroid cancer (MTC) is genetically determined in 30 % to 35 % of cases, notably through multiple mutations in the RET protooncogene located on chromosome 10, for which a genotype-phenotype relationship determines age of onset. There are three phenotypes: MEN 2 A and B, and isolated familial MTC The type of mutation determines 3 levels of aggressiveness. Current guidelines recommend thyroidectomy during the first months of life for patients with very-high-risk (level 3) mutations and before 5 years of age for high-risk (level 2) mutations. There are no precise recommendations for lower-risk mutations, for which the surgical decision also depends on the calcitonin level and family history We describe 18 patients who underwent prophylactic surgery. Regardless of the mutation, all patients with a normal preoperative cakitonin level were cured. However, surgery was performed later than recommended, for various reasons, including late genetic diagnosis and parents' opposition.
引用
收藏
页码:1247 / 1258
页数:12
相关论文
共 31 条
  • [1] Reference intervals for serum calcitonin in men, women, and children
    Basuyau, JP
    Mallet, E
    Leroy, M
    Brunelle, P
    [J]. CLINICAL CHEMISTRY, 2004, 50 (10) : 1828 - 1830
  • [2] Bihan H., 2011, HEAD NECK-J SCI SPEC, DOI [10.1002/hed 21763, DOI 10.1002/HED]
  • [3] Guidelines for diagnosis and therapy of MEN type 1 and type 2
    Brandi, ML
    Gagel, RF
    Angeli, A
    Bilezikian, JP
    Beck-Peccoz, P
    Bordi, C
    Conte-Devolx, B
    Falchetti, A
    Gheri, RG
    Libroia, A
    Lips, CJM
    Lombardi, G
    Mannelli, M
    Pacini, F
    Pondder, BAJ
    Raue, F
    Skogseid, B
    Tamburrano, G
    Thakker, RV
    Thompson, NW
    Tomassetti, P
    Tonelli, F
    Wells, SA
    Marx, SJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (12) : 5658 - 5671
  • [4] Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: Clinical manifestation and course in early and late onset disease
    Brauckhoff, M
    Gimm, O
    Weiss, CL
    Ukkat, J
    Sekulla, C
    Brauckhoff, K
    Thanh, PN
    Dralle, H
    [J]. WORLD JOURNAL OF SURGERY, 2004, 28 (12) : 1305 - 1311
  • [5] Elisei R., 2011, J CLIN ENDOCRINOL ME
  • [6] The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 - International RET mutation consortium analysis
    Eng, C
    Clayton, D
    Schuffenecker, I
    Lenoir, G
    Cote, G
    Gagel, RF
    vanAmstel, HKP
    Lips, CJM
    Nishisho, I
    Takai, SI
    Marsh, DJ
    Robinson, BG
    FrankRaue, K
    Raue, F
    Xue, FY
    Noll, WW
    Romei, C
    Pacini, F
    Fink, M
    Niederle, B
    Zedenius, J
    Nordenskjold, M
    Komminoth, P
    Hendy, GN
    Gharib, H
    Thibodeau, SN
    Lacroix, A
    Frilling, A
    Ponder, BAJ
    Mulligan, LM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19): : 1575 - 1579
  • [7] Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy:: impact of individual RET genotype
    Frank-Raue, K.
    Buhr, H.
    Dralle, H.
    Klar, E.
    Senninger, N.
    Weber, T.
    Rondot, S.
    Hoeppner, W.
    Raue, F.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 155 (02) : 229 - 236
  • [8] Update on the MEN 2A c804 RET mutation:: Is prophylactic thyroidectomy indicated?
    Frohnauer, MK
    Decker, RA
    [J]. SURGERY, 2000, 128 (06) : 1052 - 1057
  • [9] Timing and extent of surgery in patients with familial medullary thyroid carcinoma/multiple endocrine neoplasia 2A-related RET mutations not affecting codon 634
    Gimm, O
    Ukkat, J
    Niederle, BE
    Weber, T
    Thanh, PN
    Brauckhoff, M
    Niederle, B
    Dralle, H
    [J]. WORLD JOURNAL OF SURGERY, 2004, 28 (12) : 1312 - 1316
  • [10] Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation
    Gimm, O
    Marsh, DJ
    Andrew, SD
    Frilling, A
    Dahia, PLM
    Mulligan, LM
    Zajac, JD
    Robinson, BG
    Eng, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11) : 3902 - 3904